Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B SCOTT

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Journal of Pediatrics|March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1C Hutto, W P Parks, S H Lai, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1R B Geffin, G B Scott, M Melenwick, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
Pediatrics|April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivorsK Nielsen, G McSherry, A Petru, et al.
Pediatrics|February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999C Wilfert, J E Aronson, D T Beck, et al.
The Journal of Pediatrics|April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study GroupR E McKinney, P A Pizzo, G B Scott, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Clinical and Experimental Immunology|December 4, 2014
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivoY M El-Sherbiny, T D Holmes, L F Wetherill, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Journal of Pediatrics|March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1C Hutto, W P Parks, S H Lai, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1R B Geffin, G B Scott, M Melenwick, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
Pediatrics|April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivorsK Nielsen, G McSherry, A Petru, et al.
Pediatrics|February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999C Wilfert, J E Aronson, D T Beck, et al.
The Journal of Pediatrics|April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study GroupR E McKinney, P A Pizzo, G B Scott, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Clinical and Experimental Immunology|December 4, 2014
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivoY M El-Sherbiny, T D Holmes, L F Wetherill, et al.
Pageof 7